WHO ICTRP trial
Breathing effects of two opioid pain killers in healthy volunteers
EUCTR2018-003515-22-NL · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2018-003515-22-NL |
|---|---|
| Public title | Breathing effects of two opioid pain killers in healthy volunteers |
| Scientific title | Respiratory effects of tapentadol and oxycodone assessed by pharmacokinetic-pharmacodynamic and response surface modeling in healthy volunteers - SURF |
| Primary sponsor | Leiden University Medical Center |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Netherlands |
| Conditions | Chronic pain;Therapeutic area: Body processes [G] - Physiological processes [G07] |
| Interventions | Trade Name: Pallexia Product Name: Tapentadol Product Code: N02AX06 Pharmaceutical Form: Tablet Trade Name: Oxycodone Product Name: Oxycodone Product Code: RVG110728 Pharmaceutical Form: Tablet |
| Registration date | Sep 10, 2018 |
| Target size | 24 |
| Secondary IDs | SURF |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: